TAUG - Tauriga Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
3/30/2016
Total Revenue
171
57
1
0
0
Cost of Revenue
128
37
1
0
0
Gross Profit
43
20
0
0
0
Operating Expenses
Research Development
18
14
11
109
-
Selling General and Administrative
1,625
1,088
1,961
1,433
2,028
Total Operating Expenses
1,644
1,103
1,973
1,549
2,037
Operating Income or Loss
-1,601
-1,083
-1,973
-1,549
-2,037
Interest Expense
551
281
292
721
83
Total Other Income/Expenses Net
-124
268
2,189
-1
-28
Income Before Tax
-2,276
-1,095
-75
-2,271
-2,473
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-2,276
-1,095
-75
-2,271
-2,473
Net Income
-2,278
-1,097
-36
-2,271
-2,569
Net Income available to common shareholders
-2,278
-1,097
-307
-2,271
-2,569
Reported EPS
Basic
-
-0.02
-0.01
-0.12
-0.20
Diluted
-
-0.02
-0.01
-0.12
-0.20
Weighted average shares outstanding
Basic
-
55,767
52,259
19,037
12,867
Diluted
-
55,767
52,259
19,037
12,867
EBITDA
-
-814
218
-1,543
-2,380